NeuMedics Inc.
NeuMedics Inc.
  • Home
  • Leadership
    • Executive Staff
  • Macular Degeneration
    • Ophthalmic Therapies
  • NM320 for AMD
    • NM320 Eye Drops
    • Anti-inflammatory NM320
  • Contact Us
    • Contact Information
  • More
    • Home
    • Leadership
      • Executive Staff
    • Macular Degeneration
      • Ophthalmic Therapies
    • NM320 for AMD
      • NM320 Eye Drops
      • Anti-inflammatory NM320
    • Contact Us
      • Contact Information
  • Home
  • Leadership
    • Executive Staff
  • Macular Degeneration
    • Ophthalmic Therapies
  • NM320 for AMD
    • NM320 Eye Drops
    • Anti-inflammatory NM320
  • Contact Us
    • Contact Information





NeuMedics, Inc.

 

We are developing novel first-generation  eye drops targeting  Age-related macular degeneration and retino-degenerative diseases.

Contact Us

  

William D. Schwieterman, M.D., CEO

241 West 111th St. #23 | New York, New York 10026

251-377-4828 | w.schwieterman@neumedics.com

Copyright © 2025 NeuMedics Inc.  - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept